Effects of carnosine supplementation on markers for the pathophysiological development of metabolic dysfunction-associated steatotic liver disease in a diet-induced model
Articolo
Data di Pubblicazione:
2024
Citazione:
Effects of carnosine supplementation on markers for the pathophysiological development of metabolic dysfunction-associated steatotic liver disease in a diet-induced model / N.A. Grandini, M.R. Costa, C.S. Gregolin, J.S. Siqueira, T.A. Vieira, A.J. Togneri Ferron, F.V. Francisqueti-Ferron, G.R. Romualdo, A. Lúcia dos Anjos Ferreira, G. Aldini, C.R. Corrêa, F. Moreto. - In: MOLECULAR AND CELLULAR ENDOCRINOLOGY. - ISSN 0303-7207. - 582:(2024 Mar 01), pp. 112138.1-112138.10. [10.1016/j.mce.2023.112138]
Abstract:
Consumption of diets high in sugar and fat is related to the development of Metabolic dysfunction-associated steatotic liver disease (MASLD). Carnosine (CAR) is a dipeptide with antioxidant and anti-inflammatory action and has been studied for treating diseases. This work aimed to evaluate the effects of CAR on diet-induced MASLD in rats. Male Wistar rats were distributed into 2 groups (17 weeks): normocaloric (Co, n = 12), and hypercaloric diet rich in lipids and simple carbohydrates (MASLD, n = 12). After, the animals were redistributed to begin the treatment with CAR (4 weeks): Co (n = 6), Co + CAR (n = 6), MASLD (n = 6), and MASLD + CAR (n = 6), administered intraperitoneally (250 mg/kg). Evaluations included nutritional, hormonal and metabolic parameters; hepatic steatosis, inflammatory and oxidative markers. MASLD group had a higher adiposity index, systolic blood pressure, glucose, plasma and liver triglycerides and cholesterol, insulin, hepatic steatosis, oxidative markers, and lower PPAR-alpha (Peroxisome Proliferator-activated receptor alpha), compared to the Co. CAR attenuated plasma and hepatic triglyceride and cholesterol levels, hepatic steatosis, CD68+ macrophages, and hepatic oxidative markers, in addition to increasing HDL cholesterol levels and PPAR-alpha, compared to the untreated MASLD group. CAR acts in importants pathophysiological processes of MASLD and may be a therapeutic compound to control the disease.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Carnosine; Hypercaloric diet; Metabolic dysfunction-associated steatotic liver disease; Obesity
Elenco autori:
N.A. Grandini, M.R. Costa, C.S. Gregolin, J.S. Siqueira, T.A. Vieira, A.J. Togneri Ferron, F.V. Francisqueti-Ferron, G.R. Romualdo, A. Lúcia dos Anjos Ferreira, G. Aldini, C.R. Corrêa, F. Moreto
Link alla scheda completa: